Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Techniclone's Rx for B-cell NHL qualifies for orphan designation

Dec. 18, 1998

NIH offers new patented therapy for primary brain tumors for licensing

Dec. 18, 1998

Novel orally active tumor angiogenesis inhibitors licensed by Cell Therapeutics

Dec. 18, 1998

Pivotal clinical trials begin for Epic's sustained-release LHRH analogue

Dec. 18, 1998

British Biotech discontinues marimastat monotherapy study in ovarian cancer

Dec. 17, 1998

Liposome Co. files for approval of Evacet in U.S.

Dec. 17, 1998

Orphan Medical files NDS for Busulfex Injection in Canada

Dec. 17, 1998

Merck KGaA prefers alliances to mergers; signs new deal with ImClone Systems

Dec. 16, 1998

Phase II trials of Xenova's P-gp pump inhibitor planned in U.S. and U.K.

Dec. 16, 1998

Clinical studies support excellent safety and efficacy of Busulfex

Dec. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...